Good morning.
We’re taking a moment to remember all those lost on 9/11.
In the cannabis world, states collected $3.55 billion in cannabis excise taxes last fiscal year, and a federal appeals court tossed a $31.8 million verdict because cannabis contracts aren't enforceable in federal court.
We’ll break all that down and more on today’s This Week in Cannabis Live. See you there on LinkedIn » and YouTube ».
Let’s get to it.
-JB, JR
Today’s newsletter is 872 words or about a 7-minute read.
📅 CULTIVATED CALENDAR
September 11 » Cultivated Live → How a Queens cannabis shop turns the US Open into a sales play with Stephen Gold
September 11 » This Week in Cannabis Live → Rescheduling survives its first court test
September 24 » Webinar → Metrc is here. Now what? Making track-and-trace work for your New York cannabis business
Stay tuned next week for Cultivated’s full line up of Q4 events.
What’s the big deal?
DENIED
States collected $3.55 billion in cannabis excise taxes in fiscal 2026

What happened: Thirty states and D.C. pulled in an estimated $3.55 billion in cannabis taxes between July 2025 and June 2026, according to the Census Bureau. That's up 15.7% from fiscal 2022, when the bureau started tracking the data.
Eleven states entered the market in that stretch, most recently Alabama with medical sales in May.
What's driving it: Washington and Montana lead per capita at more than $50 per resident, thanks to retail excise rates of 37% and 20%.
Minnesota more than doubled its haul to $34.44 million after raising its rate to 15% and issuing 324 new licenses. Delaware, which started collecting in August 2025, is still ramping up.
Why it matters: The bureau's own framing is that states are trying to raise revenue without pricing consumers into the illicit market.
California is the cautionary tale: Revenue fell from $879 million to $528 million after it killed its cultivation tax and legal prices collapsed.
What's next: Every new market adds to the total, but the tax-rate tinkering never stops.
Quotables
Aurora CEO Miguel Martin is taking a more offensive posture on social media lately against Curaleaf’s hostile bid:
“One question shareholders should ask is simple: Why is Curaleaf pursuing Aurora?” he said on LinkedIn.
“The answer speaks directly to the value of the platform Aurora shareholders already own. Aurora has spent years building EU-GMP cultivation capacity, regulatory expertise and leading positions in key European medical cannabis markets. Curaleaf cannot replicate the foundation of our international growth strategy, and they know it.”
Lawsuits
Sixth Circuit tosses $31.8 million verdict against Curaleaf subsidiaries
A federal appeals court threw out a jury award to Michigan grower Hello Farms, ruling that because selling cannabis is still a federal felony, federal courts can't enforce cannabis contracts. The panel said April's Schedule III rule doesn't help, since it isn't retroactive and only covers medical cannabis. $CURLF ( ▼ 3.63% )
Cookies ordered to pay investors $61.5 million in arbitration
An arbitrator ruled that Cookies and president Parker Berling defrauded investors Gron Ventures and Red Tech by scrapping a $57 million buyout of their stakes and pushing through a "sham" Series A to wipe out their rights. Berner has since left the company and is suing it from his new entity, Cookies SF, leaving Berling as its sole remaining director.
Quick hits
US Cannabis Roundtable lobbies to keep intoxicating hemp ban on track
The cannabis industry trade group met with 26 House offices last week to push for closing the 2018 farm bill loophole, after Congress delayed the ban's effective date to December 11. The House canceled votes for the last two weeks of September, leaving little floor time before the deadline.
Ivy Hall gets approval to serve medical patients at 10 Illinois stores
Illinois' largest independent retailer got the green light from state regulators to serve medical patients, who get an excise tax exemption and higher purchase limits than recreational customers. Its two Chicago locations, Bucktown and Logan Square, are still waiting on city permits.
Maryland and D.C. move to ease barriers for small cannabis operators
Maryland regulators are seeking a nonprofit to run a state-owned incubator with shared processing space for social equity micro-licensees, with responses due September 28. Across the border, D.C. enacted emergency legislation letting conditional medical licensees convert to full licenses with a zoning certificate instead of a certificate of occupancy through October 28.
Seed retailer makes the business case for federal home grow rights
Blimburn Seeds published a white paper arguing home cultivation is an untapped market for grow equipment, nutrients and seeds, and calling for a federal baseline that would override the 11 legal states that still ban it. The paper leans on a survey of the company's own customers, 97% of whom, unsurprisingly, want the right to grow.
People moves
Village Farms named Hamid Shekarchi, previously CFO of its Canadian cannabis unit, as interim CFO, succeeding Steve Ruffini, who shifts to overseeing M&A. $VFF.TSX ( ▼ 3.7% )
Deals, launches, partnerships
Cannara Biotech expanded its credit facility to C$80 million with BMO and TD, bumping its revolver from $10 million to $40 million and pushing maturity out to 2029 to fund its Valleyfield expansion. $LOVE.TSX ( ▼ 0.26% )
Dylan Balaban was promoted to sales manager at Green Thumb Industries in New York. $GTBIF ( ▼ 4.34% )
What we’re reading
Congress banned fake hemp. Don’t let them carve out an exception for weed soda | Washington Examiner
